Keyphrases
Lipid-lowering Therapy
100%
United States
100%
Confidence Interval
100%
Adjusted Odds Ratio
100%
Primary Prevention
100%
Low-density Lipoprotein Cholesterol (LDL-C)
100%
Patients with Diabetes
100%
Health Systems
100%
High-intensity Statin Therapy
42%
High-intensity Statin
42%
Type 2 Diabetes Mellitus (T2DM)
28%
1-year Follow-up
28%
Statins
28%
Type 2 Diabetic Patients
28%
Statin Therapy
28%
Atherosclerotic Cardiovascular Disease (ASCVD)
28%
Therapy Utilization
28%
Chronic Kidney Disease
14%
Hypertension
14%
Rheumatoid Arthritis
14%
Low Intensity
14%
Low-density Lipoprotein Cholesterol Level
14%
Multivariable Logistic Regression
14%
National Guidelines
14%
Community Practice
14%
Hepatitis C
14%
Retinopathy
14%
Inflammatory Conditions
14%
Psoriasis
14%
Ezetimibe
14%
Cerner
14%
Electronic Health
14%
Nursing and Health Professions
Confidence Interval
100%
Odds Ratio
100%
Primary Prevention
100%
Low Density Lipoprotein Cholesterol
100%
Statin (Protein)
71%
Statins therapy
57%
Non Insulin Dependent Diabetes Mellitus
28%
Patient with Type 2 Diabetes
28%
Coronary Artery Atherosclerosis
28%
Low Density Lipoprotein Cholesterol Level
14%
Practice Guideline
14%
Logistic Regression Analysis
14%
Inflammation
14%
Rheumatoid Arthritis
14%
Chronic Kidney Failure
14%
Psoriasis
14%
Hepatitis C
14%
Retinopathy
14%
Cerner
14%
Ezetimibe
14%
Medicine and Dentistry
Diabetes
100%
Health System
100%
Primary Prevention
100%
Statin
100%
Low Density Lipoprotein Cholesterol
100%
Odds Ratio
77%
Maturity Onset Diabetes of the Young
22%
Patient with Type 2 Diabetes
22%
Chronic Kidney Disease
11%
Serositis
11%
Logistic Regression Analysis
11%
Hepatitis C
11%
Retinopathy
11%
Psoriasis
11%
Rheumatoid Arthritis
11%
Ezetimibe
11%